Eirion Reports AI-09 Trial Results for Injectable Neuromodulator
01 Oct 2024 //
PR NEWSWIRE
Eirion Therapeutics to Present at the 2024 IMCAS WORLD CONGRESS
02 Feb 2024 //
PR NEWSWIRE
Eirion Therapeutics to Participate in the 2023 IMCAS WORLD CONGRESS
26 Jan 2023 //
PR NEWSWIRE
Eirion Announces Initiation of First-in-Human Clinical Trial Evaluating AI-09
17 Oct 2022 //
PRNEWSWIRE
Eirion Therapeutics Announces Strategic Agreement for HTL Biotechnology
08 Sep 2021 //
PRNEWSWIRE